You are here

  • Home
  • Archive
  • Volume 102, Issue Suppl 3
  • 4 Troponin positive acute coronary syndromes and unobstructed coronary arteries: Improved diagnostic and clinical impact by performing cardiovascular magnetic resonance early after presentation

Article Text

Article menu

Download PDFPDF

Abstracts
4 Troponin positive acute coronary syndromes and unobstructed coronary arteries: Improved diagnostic and clinical impact by performing cardiovascular magnetic resonance early after presentation
Free
  1. A Ghosh Dastidar1,2,
  2. J Rodrigues1,3,
  3. T Johnson1,2,
  4. E De Garate1,
  5. P Singhal2,
  6. A Baritussio1,
  7. A Scatteia1,
  8. J Strange1,
  9. A Nightingale1,2,
  10. A Baumbach1,2,
  11. V Delgado4,
  12. C Bucciarelli-Ducci1,2
  1. 1NIHR Bristol Cardiovascular Biomedical Research Unit, Bristol Heart Institute, UK
  2. 2School of Clinical Sciences, Faculty of Health Sciences, University of Bristol, UK
  3. 3School of Physiology, Pharmacology and Neuroscience, Faculty of Biomedical Sciences, University of Bristol University of Bristol, UK
  4. 4Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands

Abstract

Background 7–15% of acute coronary syndrome (ACS) patients have unobstructed coronary arteries. In these patients cardiac magnetic resonance (CMR) can identify different underlying aetiologies.

Aim Evaluate the diagnostic and decision making implications of CMR timing (early versus late) in patients with ACS and unobstructed coronary arteries.

Methods 204 consecutive patients (mean age 55yrs, 51% males) with troponin positive ACS and unobstructed coronary arteries, referred for a CMR between September 2011 and July 2014 were evaluated. Comprehensive CMR was performed “early” (≤2weeks from presentation) in 98 patients and “late” (>2weeks from presentation) in 106. “Significant clinical impact” was predefined as change in diagnosis/management. Propensity matching was performed between early and late CMR groups to minimise selection bias.

Results Overall, a cause was found in 70% of patients. CMR had significant clinical impact in 66%, including change in the final diagnosis in 54%. (Figure 1) In a multivariable model (included clinical and imaging parameters), presence of late gadolinium enhancement (LGE) and age were the only independent predictors of “significant clinical impact” (LGE OR 2.3, p = 0.02) (Table 1). In a propensity score analysis, 58 pair of patients was matched for early and late CMR. The diagnostic pick up rate in the “early” group was significantly higher than in the “late” group (88% vs 50% p < 0.0001). Myocarditis (33%) was the most common diagnosis in the “early” group, whereas myocardial infarction (22%) in the “late” group. The clinical impact also improved significantly in the early group compared to the propensity score matched late group (76% vs 51%, p = 0.01).

Conclusion CMR was able to establish final diagnosis in overall 70%. CMR made significant additive clinical impact on management and diagnosis in 66%, with LGE being the best independent predictor of impact. Moreover, the diagnostic value as well as the clinical impact of CMR was highest when performed early.

Abstract 4 Figure 1
Abstract 4 Figure 1

Showing the change in diagnosis following CMR

View this table:
Abstract 4 Table 1

Predictors of clinical impact – univariate and multivariate logistic regression analysis

https://doi.org/10.1136/heartjnl-2016-309668.4

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.